Ist survey (marked with A in Table 2.) | EUROASPIRE III. | IInd survey (marked with D in Table 2.) | EUROASPIRE IV. | |
---|---|---|---|---|
Study period | 2010–2011 | 2006–2007 | 2015–2016 | 2014–2015 |
Study field | Hungary | 12 European countries | Hungary | 14 European countries |
Base of risk assessment | Fourth Joint European Task Force Guideline | Fifth Joint European Task Force Guideline | ||
Risk level | High-risk without CVD | High-risk without CVD | ||
BLOOD PRESSURE | ||||
Target value [mmHg] | < 140/90 | < 140/90 | < 140/90 (with DM: 140/85) | < 140/90 (with DM: 140/80) |
Patients on target [%] | 75.8 | 36.1 | 60.0 | 44.7 |
TOTAL-CHOLESTEROL | ||||
Target value [mmol/l] | < 5.0 | < 5.0 | ||
Patients on target [%] | 33.9 | 33.7 | ||
LDL-CHOLESTEROL | ||||
Target value [mmol/l] | < 2.5 | < 2.5 | ||
Patients on target [%] | 39.3 | 32.7 | ||
Risk level | High risk DM patients without CVD | |||
HbA1c | ||||
Target value [%] | < 7 | < 7 | < 7 | < 7 |
Patients on target [%] | 48.8 | 39.9 | 43.0 | 58.5 |